Abstract
Conidiobolomycosis is a rare mycotic disease caused by Conidiobolus coronatus. Very few cases have been reported in English literature. Often it is clinically misdiagnosed as soft tissue tumour. A prospective case study was done from 2006 to 2015 in a tertiary care hospital of West Bengal, India. The objectives of our study were to describe the epidemiological and clinical features and treatment of Conidiobolomycosis to prevent disfigurement. Patients clinically suspected to be suffering from Conidiobolomycosis were subjected to biopsy followed by histopathological and mycological examinations. Then they were treated with oral saturated solution of potassium iodide along with other drugs. Total six cases were histopathologically proved to be suffering from Conidiobolomycosis. Fungus was isolated and identified in one case. Complete resolution was seen in five patients. Conidiobolomycosis should be brought into mind as differential diagnosis of subcutaneous swelling in the rhinofacial region.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Conidiobolomycosis is a rare, chronic, localized, subcutaneous zygomycosis of rhinofacial region [1, 2]. It is caused by Conidiobolus coronatus [3]. It is characterized by painless, woody swelling of rhinofacial region [1, 2], often clinically misdiagnosed as soft tissue tumour [4]. The disease occurs mainly in South East Asia, Africa, South and Central America. Very few cases have been reported from India [5]. Due to the small number of cases reported in the literature, treatment protocol is not yet standardized [6]. Here we describe six cases, diagnosed on the basis of clinical knowledge and histopathological features.
Materials and Methods
We conducted our study over 10 years (from January 2006 to December 2015) in a tertiary care hospital of West Bengal, India. We treated patients referred to our hospital from all over West Bengal. The objectives of our study were to describe the epidemiological features, and diagnostic and treatment protocols of patients of Conidiobolomycosis.
Patients clinically suspected to be suffering from Conidiobolomycosis were subjected to biopsy followed by histopathological and mycological examinations. Informed consent was obtained for participation in this study and publication also. This study was approved by the institutional ethical committee. Total six cases were histologically and/or mycologically proved and included in our study (Figs. 1, 2, 3, 4, 5, 6). A detailed history was taken and local examination was done (Tables 1, 2). General and systemic examinations were also done. All patients underwent routine blood tests and CT scan of nose and paranasal sinuses (Fig. 7). Biopsy was taken from the swelling in anterior end of inferior turbinate or ala of nose and tissue was sent for histopathological examination and mycological culture. Patients were treated with oral saturated solution of potassium iodide (SSKI) along with other drugs (Table 3). Patients were advised to take SSKI with fresh fruit juice. Initially it was given 5 drops/dose thrice daily and gradually increased up to 15 drops/dose thrice daily. Before and during treatment, patient’s thyroid function test, liver function test and serum potassium were monitored. We advised local hot compression over nose and face, and mouthwash with luke warm water in cases having involvement of oral cavity. We also prescribed natamycin topical 5% suspension intra-nasally. Regular follow up was done and treatment was continued for another 3 months after complete resolution.
Results
In our series total number of patients was six. All were from rural area. Five of them were male, one was female. All patients were involved in agricultural activity either directly or indirectly. Nasal obstruction was the most common and earliest symptom. None of them had history of fever or trauma to nose. All of them had swelling either in the ala or inferior turbinate of nose along with swelling of dorsum of nose, cheek, upper lip or glabella. The margin of the swelling was ill-defined, surface was smooth and shiny. Slight coppery discolouration was obvious on the skin over the swelling in some cases but there was no ulceration. On palpation there was no tenderness, no hypoesthesia or hyperaesthesia over the swelling, the consistency was firm and the overlying skin was thickened and fixed. Local temperature was not raised and the swelling was not pulsatile. There was no significantly palpable lymph node in neck. Systemic examinations were within normal limits. Histopathological examination of biopsied specimen showed sparse hyphal elements ensheathed by amorphous eosinophilic Splendore-Hoeppli material (Fig. 8). Culture was positive in only one patient that was too on second attempt, which showed white waxy to powdery colonies (Fig. 9). On microscopy, broad septate hyphae with unbranched short, erect conidiophores were seen (Fig. 10). Complete resolution was seen in five patients. There were multiple recurrences in one patient. In one patient it recurred due to discontinuation of treatment in the midway.
Discussion
Conidiobolomycosis is a chronic, localized, subcutaneous zygomycosis [1, 2]. It is caused by Conidiobolus coronatus, a mould belonging to the order Entomophthorales of the class Zygomycetes [3]. Because of its initially central facial presentation affecting the nose first, the disease is known as rhinoentomophthoromycosis [6]. The name Entomophthorales has been derived from Greek word “Entomon”, which means insect [1]. These are saprophytic fungi present in soil, decaying fruit and vegetable matter as well as in the gut of amphibians and reptiles. Basically these fungi are pathogens infecting insects [5]. The human pathogens in this order include Basidiobolus ranarum and Conidiobolus coronatus [7]. Infection by B. ranarum manifests itself as a subcutaneous tumefaction located on the trunk, buttocks, or proximal portion of the limbs [6]. The infection is transmitted by inhalation of spores, insect bites or their introduction into the nasal cavities by soiled hands [8]. Conidiobolus coronatus was first identified as an agent of nasal granulomatous disease in horse in Texas in 1961, while the first human infection was reported in Jamaica in 1965 by Bras et al. [1]. It occurs predominantly in males with agricultural or outdoor occupations, with a male to female ratio of 10:1 [9]. In our study the ratio was 5:1. All of them came from rural area and were involved in agricultural activity either directly or indirectly. The disease is usually seen in immunocompetent patients. However, there have been reports in HIV infected patients and renal transplant patients [10, 11]. The disease seems to start in inferior turbinate followed by submucosal spread to the subcutaneous tissues of dorsum of nose, cheeks, forehead, periorbital region and upper lip [12, 13]. Nasal obstruction occurs first, followed by a diffuse erythematous infiltration with thickening of the skin on the nose and face. Later it causes discomfort and restriction of movement of the face and upper lip [14]. Development of subcutaneous nodules in the eyebrows, upper lip and cheeks may give the patient the appearance of hippopotamus [15]. In the more advanced cases, the lesions can also affect the nasopharynx, oropharynx, palate and laryngopharynx [16, 17]. It rarely extends to the intracranium, mediastinum or lungs [18, 19]. All of our patients complained of unilateral or bilateral nasal obstruction. They showed swelling either in the ala or inferior turbinate of nose along with swelling of dorsum of nose, cheek (nasolabial and nasofacial region), upper lip or glabella. One case had developed swelling of palate. The lesion is occasionally misdiagnosed clinically as cellulitis, rhinoscleroma, lymphoma, lymhoedema, Kimura disease, angiolymphoid hyperplasia with eosinophilia and sarcoma [7, 14]. On histopathological examination hyphae of Conidiobolus coronatus are difficult to find as they are outnumbered by numerous commensal fungi. Hyphae of Conidiobolus coronatus are short and broad with conspicuous septation. They are ensheathed by amorphous eosinophilic Splendore-Hoeppli material, which is believed to be an antigen–antibody precipitate. The adjacent stroma consists of granulation tissue that is rich in eosinophils [8]. Only 15% of Conidiobolomycosis are positive on mycological culture from clinical specimens [20, 21] as hyphae are often damaged and become non-viable during biopsy procedure or by chopping up or grinding processes in the laboratory. Their growth is also superseded by commensal fungi [22,23,24]. Only one patient (16.67%) in our study had positive culture. Conidia are forcibly discharged and stick to the walls of the culture container forming waxy to powdery colonies completely clouding the view of the culture with time [1]. On microscopy, broad septate hyphae with unbranched short, erect conidiophores are seen [1]. Various treatment protocol have been tried with mixed results. Medications used to treat Conidiobolomycosis include SSKI, ketoconazole (200–400 mg/day), itraconazole (200–400 mg/day), fluconazole (100–200 mg/day), miconazole, voriconazole, terbinafine, amphotericin B, clotrimazole and hyperbaric oxygen [3, 25, 26]. Of these, itraconazole and fluconazole are both effective and relatively safe [6]. SSKI (1 gm/ml) is useful for patients in developing countries, because of its ease of administration and low cost. It is initiated in a dose of 5 drops/day (diluted in water, milk or fruit juice) and gradually increased up to a maximum of 40–50 drops per day, as tolerated [27]. The exact mechanism of its action is not known. Iodide perhaps facilitates phagocytic killing by promoting the respiratory burst associated with superoxide formulation in phagolysosomes [28]. Iododerma, acneiform eruption, gastric intolerance, increased salivation and lacrimation, unpleasant brassy taste, hypothyroidism etc. are the usual side effects [8]. Combination therapy with oral potassium iodide and oral azoles give rapid and lasting results [8]. We found good result with topical thermotherapy similar to a report by Haruna et al. [29]. We also got acceptable result with intranasal use of topical natamycin, which is actually prescribed for mycotic keratitis [30]. Relapse is common, even after successful treatment [7, 8]. In such cases systemic steroid is used. Steroids probably act as adjuvant to inhibit deposition of a barrier eosinophilic immune complex around the fungus thereby ensuring availability of antifungal drugs to the target site [31]. Two patients of our study had recurrence. One of them was cured with treatment after initial course of oral steroid. Others were completely cured. Treatment should be continued for at least 3 months after the lesions have cleared [8]. Surgical resection is seldom helpful and it may hasten the spread of infection.
Conclusion
Conidiobolomycosis should be brought into mind as differential diagnosis of subcutaneous swelling in the rhino-facial region especially in adult male agricultural workers. Look of the patient is the mainstay of diagnosis. Excessive tissue damage has to be avoided during biopsy. Similarly teasing and processing of the specimen should be gentle to avoid damage to the hyphae during culture. Fungal hyphae are to be searched meticulously under microscope as they are outnumbered by commensal fungi. Treatment should be started on the basis of histopathological report as culture is often negative. No treatment is standardized yet worldwide. Treatment should be continued for at least 3 months after complete resolution. With increasing awareness of the disease and expansion of mycological diagnostic facilities, we can expect more frequent reporting of the disease.
References
Ribes JA, Vanover-Sams CL, Baker DJ (2000) Zygomycetes in human disease. Clin Microbiol Rev 13(2):236–290
Richardson MD, Warnock DW (2003) Entomophromycosis. In: Richardson MD, Warnock DW (eds) Fungal infection. Diagnosis and management, 3rd edn. Blackwell Publishing, Oxford), pp 293–297
Chayakulkeeree M, Ghannoum MA, Perfeft JR (2006) Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis 25:215–229
Thotan SP, Kumar V, Gupta A, Mallya A, Rao S (2010) Subcutaneous phycomycosis-fungal infection mimicking a soft tissue tumor: a case report and review of literature. J Trop Pediatr 56(1):65–66
Sujatha S, Sheeladevi C, Khyriem AB, Parija SC, Thappa DM (2003) Subcuteneous zygomycosis caused by Basidiobolus ranarum—a case report. Indian J Med Microbiol 21(3):205–206
Valle AC, Wanke B, Lazera MS, Monteiro PC, Veigas ML (2001) Entomophthoromycosis by Conidiobolus coronatus. Report of a case successfully treated with the combination of itraconazole and fluconazole. Rev Inst Med Trop Sao Paulo 43:233–236
Shetty D, Rai S, Shetty S, Jagdish Chandra K, Kini H, Bhat S (2014) Rhinofacial zygomycosis—a rare and interesting case. Otolaryngol Online J 4(4):265–272
Thomas MM, Bal SM, Jayaprakash C, Jose P, Ebenezer R (2006) Rhinoentomophthoromycosis. Indian J Dermatol Venereol Leprol 72(4):296–299
Martinson FD, Clark BM (1967) Rhinophycomycosis entomophthorae in Nigeria. Am J Trop Med Hyg 16:40–47
Boonsarngsuk V, Suankratay C, Wilde H (2001) Presumably entomophthoramycosis in a HIV-infected patient: the first in Thailand. J Med Assoc Thail 84:1635–1639
Walker SD, Clark RV, King CT, Humphries JE, Lytle LS, Butkus DE (1992) Fatal disseminated Conidiobolus coronatus infection in a renal transplant patient. Am J Clin Pathol 98:559–564
Ochoa LF, Duque CS, Velez A (1996) Rhinoentomophthoromycosis—report of two cases. J Laryngol Otol 110:1154–1156
Mukhopadhyay D, Ghosh LM, Thammayya A, Sanyal M (1995) Entomophthoromycosis caused by Conidiobolus coronatus: clinicomycological study of a case. Auris Nasus Larynx 22(2):139–142
Leopairut J, Larbcharoensub N, Cheewaruangroj W, Sungkanuparph S, Sathapatayavongs B (2014) Rhinofacial entomophthoramycosis; a case series and review of the literature. Southeast Asian J Trop Med Public Health 41(4):928–935
Restrepo A (1994) Treatment of tropical mycoses. J Am Acad Dermatol 31:91–102
Bandeira V, Lascet IG (1995) Zigomicose. In: Talhari S, Neves RG (eds) Dermatologia tropical. Medsi, São Paulo, pp 191–202
Ellis DH (1998) The zygomycetes. In: Ajello L, Hay RJ (eds) Medical mycology, 9th edn. Oxford University Press, New York, pp 247–276 (Collier L, Balows A, Sussman M Topley and Wilson’s microbiology and microbial infections v.4.)
Gilbert EF, Khoury GH, Pore RS (1970) Histopathological identification of entomophthora phycomycosis in deep mycotic infection in an infant. Arch Pathol 90:583–587
Hoogendijk CF, van Heerden WF, Pretorius E, Vismer HF, Jacobs JF (2006) Rhino-orbitocerebral entomophthoramycosis. Int J Oral Maxillofac Surg 35:277–280
Akpanonu BE, Ansel G, Karurich JD, Savolaine ER, Campbell EW, Myles JL (1991) Zygomycosis mimicking paranasal malignancy. Am J Trop Med Hyg 45:390–398
Balraj A, Anandi V, Raman R (1991) Rhinofacial conidiobolomycosis. Ear Nose Throat J 70:737–739
Rippon JW et al (1982) Medical mycology, 2nd edn. W. B. Saunders Co, Philadelphia
Chandler FW, Watts JC (1996) Fungal diseases. In: Damjanov I, Linder J (eds) Anderson's pathology. 10th edn. St. Louis, C.V. Mosby Company, MO, pp 951–984
Ellis DH (2005) Systemic Zygomycetes-Mucormycosis. In: Merz WG, Hay RJ (ed) Topley and Wilson’s Microbiology and Microbial Infections, Medical Mycology, 10th edn. Hodder Arnold, London, pp 659–686
Prabhu RM, Patel R (2004) Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 10(suppl 1):31–47
Sugar AM (2005) Agents of mucormycosis and related species. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, vol 2, 6th edn. Churchill Livingstone, Philadelphia, pp 2980–2981
Loreetta SD (2001) Newer uses of older drugs: an update. In: Stephen EW (ed) Comprehensive dermatologic drug therapy, 1st edn. WB Saunders Company, Philadelphia, pp 426–444
Ramesh A, Deka RC, Vijayaraghavan M, Ray R, Kabra SK, Rakesh K, Manoj K (2000) Entomophthoromycosis of the nose and paranasal sinus. Indian J Pediatr 67(4):307–310
Haruna K, Shiraki Y, Hiruma M, Ikeda S, Kawasaki M (2006) A case of lymphangitic sporotrichosis occurring on both forearms with a published work review of cases of bilateral sporotrichosis in Japan. J Dermatol 33(5):364–367
Thomas PA (2003) Current perspectives on ophthalmic mycoses. Clin Microbiol Rev 16(4):730–797
Maiti PK, Bandyopahyay D (1999) Case of entomophthoromycosis refractory to conventional therapy. Indian J Med Microbiol 17(3):150–151
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Das, S.K., Das, C., Maity, A.B. et al. Conidiobolomycosis: An Unusual Fungal Disease—Our Experience. Indian J Otolaryngol Head Neck Surg 71 (Suppl 3), 1821–1826 (2019). https://doi.org/10.1007/s12070-017-1182-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12070-017-1182-6